Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CD Calcitonin gene-related peptide (CGRP) antagonists
N02CD04 Ubrogepant
D10673 Ubrogepant (USAN/INN) <US>
USP drug classification [BR:br08302]
Antimigraine Agents
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist
Ubrogepant
D10673 Ubrogepant (USAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10673 Ubrogepant
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Calcitonin
CALCRL
D10673 Ubrogepant (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10673
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10673
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10673